key: cord-0836668-wokwq7go
authors: Masjedi, Marjan; Pourazizi, Mohsen; Hosseini, Nastaran‐Sadat
title: Acute macular neuroretinopathy as a manifestation of coronavirus disease 2019: A case report
date: 2021-10-17
journal: Clin Case Rep
DOI: 10.1002/ccr3.4976
sha: 281e768848eec1aa92420987ef1df73bd6d4279f
doc_id: 836668
cord_uid: wokwq7go

The current findings is important in raising clinicians' awareness of the possibility of coincident acute macular neuroretinopathy (AMN) and COVID‐19 as a potential cause of retinal vascular damage and ischemia.

This is a new case of simultaneous occurrences of AMN and COVID-19 in a previously healthy woman. The importance of the current report lies in increasing the awareness of all physicians about the probable association of COVID-19 with retinal vascular injury and ischemia. Acute macular neuroretinopathy (AMN) is a rare retinal involvement characterized by a wedge-shaped reddishbrown lesion extending toward the fovea, usually resulting in a sudden onset paracentral scotoma. The lesions are reported predominantly in young, healthy female individuals. 1 The clear etiology of AVM is not entirely understood. Oral contraceptive use, caffeine, trauma, cocaine abuse, viral and flu-like illness, sympathomimetic medications, and vaccination use are all factors associated with the AVM. Several studies have stated that most cases are attributed to an initial flu-like condition, but no concrete evidence of a link with influenza has been identified to date. 2 Exploring the literature elucidates the wide-spectrum tissue tropism and multi-organ complication of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection issued from the angiotensin-converting enzyme 2 (ACE-2), the primary receptor of the virus, since the coronavirus disease 2019 (COVID-19) pandemic's onset. Ocular manifestations were initially described as ocular surface diseases such as conjunctivitis. 3 Recently, there has been speculation about retinal involvement in fundus ophthalmoscopy and optical coherence tomography, including AVM. 4-6 Virgo J et al. announced two cases of PAMM and AMN concurrent with the course of the SARS-CoV-2 infection. 7 Our report describes a new instance of COVID-19associated AMN that manifested as unilateral acute onset scotoma following SARS-CoV-2 infection in a 29-year-old woman who had no previous medical history to report. In addition to introducing this unique association, we review the relevant literature.

A 29-year-old woman was presented with a chief complaint of experiencing acute onset paracentral visual field defect from 5 days ago in the left eye. She had a positive SARS-CoV-2 reverse transcription-polymerase chain reaction (RT-PCR) test in past medical history, performed following fever, headache, and non-productive cough 2 weeks before the beginning of ocular symptoms. The symptom was mild, so the patient was advised to selfquarantine without receiving any specific medication. The mild respiratory symptoms were relieved by the use of paracetamol and diphenhydramine. Previous ocular, medical and family histories were unremarkable except COVID-19. She had no prior history of medications consumption, sun-gazing, or eye trauma.

Ophthalmological examination revealed equally round and reactive to light and accommodation pupils with normal slit-lam bio-microscopy. Intraocular pressure was normal. The fundoscopic evaluation demonstrated a sharply contoured and well-perfused disc as well as a yellow spot in the fundus left eye.

Infrared imaging revealed a subtle, grayish wedgeshaped lesion surrounding the fovea compatible with the hypo-reflective area in the left eye. Additionally, spectral-domain optical coherence tomography (SD-OCT) demonstrated the disruption of the inner segment/outer segment junction (ellipsoid zone) (Figure 1 ). Based on patient history and ocular assessments, the possible diagnose of AMN associated with COVID-19 was made.

Two months following the initial ophthalmology appointment, the condition began to fade gradually; however, the patient continued to complain of a visual field defect ( Figure 2 ).

Although the exact etiopathogenesis of AMN is unclear, the proposed mechanism of AMN related to local or systemic vasculopathic injuries includes retinal vascular injuries or systemic underlying vasculopathic conditions.

The existence of ACE-2 in the retina has indicated the posterior segment of the eye as a potential virus target. However, there is still a controversy on the verified relation between retinal damages and the SARS-CoV-2 infection. Discrepancies about the presence of SARS-CoV-2 RNA in the histopathologic analysis of the retina may warrant further investigations. Limited case reports highlighted that AMN could be related to SARS-CoV-2 infection. 4, 8, 9 It was hypothesized that the retinal capillary plexus ischemia leading to AMN could be secondary to an acquired hypercoagulable state associated with COVID-19, especially in the inflammatory phase. In the course of COVID-19, on the one hand, hypercoagulable state results in pro-thrombotic endothelial lesions and overactive immune response and cytokine storm, which cause local and systemic vascular injuries. On the other hand, Our case report features a convalescent COVID-19 young female patient and a subsequent retinal involvement. SARS-CoV-2 infection is considered the presumptive etiology of retinal vascular ischemia without any other established etiological factors. There are clear limitations to the methodology of case studies in determining pathogenesis and predisposing factors, particularly in rare conditions. Nonetheless, we emphasize the potential association of AMN and COVID-19. However, future researches are needed to understand the exact etiopathogenesis.

Acute macular neuroretinopathy: a comprehensive review of the literature

Acute macular neuroretinopathy associated with acute influenza virus infection

ACE2 and TMPRSS2 are expressed on the human ocular surface, suggesting susceptibility to SARS-CoV-2 infection

Covid-19-associated retinopathy: a case report article history

Low visual acuity due to acute macular neuroretinopathy associated with COVID-19: a case report

Acute macular neuroretinopathy in a patient with acute myeloid leukemia and deceased by COVID-19: a case report

Paracentral acute middle maculopathy and acute macular neuroretinopathy following SARS-CoV-2 infection

Acute macular neuroretinopathy as the presenting manifestation of COVID-19 infection. Retin Cases Brief Rep

Paracentral acute middle maculopathy following CoV-2 infection: the D-dimer hypothesis

A patient with acute macular neuroretinopathy and central retinal vein occlusion

COVID-19-associated central retinal vein occlusion treated with oral aspirin

Acute macular neuroretinopathy as a manifestation of coronavirus disease 2019: A case report

The authors would like to express their gratitude to the patient who accepted to participate in this study and to the Isfahan university of medical sciences for their assistance in preparing this manuscript for publication.

There are no conflicts of interest reported by the authors. The authors are solely responsible for the article's content and writing.

Marjan Masjedi involved in the patient management and performed investigation. Nastaran-Sadat Hosseini wrote the initial draft and reviewed the literature. Mohsen Pourazizi revised the manuscript and approved the final version. All authors have contributed to the preparation of this manuscript and have reviewed it prior to submission.

Ethics approval for this report was obtained from the Ethics Committee of Isfahan University of Medical Sciences, Isfahan, Iran (IR.MUI.MED.REC.1400.423).

The patient was provided with written informed consent to participate in the study.

The data used to support this study's findings can be obtained from the corresponding author upon written request.

Mohsen Pourazizi https://orcid. org/0000-0002-9714-8209 Nastaran-Sadat Hosseini https://orcid. org/0000-0001-7705-7783